​

Funding Round

Series D - BioAge Labs

Series D - BioAge Labs

Investment Firm

Overview

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Announced Date

Feb 13, 2024

Closed on Date

Feb 13, 2024

Funding Type

Series D

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

14

Investor Name
Participant InvestorSands Capital Ventures
Participant InvestorFelicis
Participant InvestorAndreessen Horowitz
Participant InvestorSV Health Investors
Participant InvestorOUP (Osage University Partners)

Round Details and Background

BioAge Labs raised $170000000 on 2024-02-13 in Series D

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 03, 2020
Series C - BioAge Labs
9-90.0M
Jul 28, 2017
Series A - BioAge Labs
7-10.9M
Sep 18, 2017
Seed Round - BioAge Labs
1-undefined
Feb 13, 2024
Series D - BioAge Labs
14-170.0M

Recent Activity

There is no recent news or activity for this profile.